SCCM
Log In
Forgot username or password?
New User? Sign Up Free.

Tag: Anticoagulation

Anticoagulation guidelines for COVID 19 patients
This resource details anticoagulation guidelines for COVID-19 patients. This is a community developed COVID-19 microlearning resource.

Anticoagulation, Coronavirus, COVID-19, Therapies


SCCM Pod-VCCR2 New Onset Atrial Fibrillation in Septic Shock
Sean P. Kane, PharmD, BCPS, speaks with Ishaq Lat, PharmD, about new onset atrial fibrillation in septic shock. In the epsiode, the issue of rate versus rhythm control is discussed as well as the need for anticoagulation among this patient population.

Anticoagulation, Sepsis, Septic Shock


Anticoagulation Issues
This presentation covers treating anticoagulation issues seen in COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

Anticoagulation, Coronavirus, COVID-19


Anticoagulation Issues in COVID-19
This presentation covers anticoagluation issues seen with COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

Anticoagulation, Coronavirus, COVID-19


Can you discuss coagulability issues?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on May 13th, 2020.

Anticoagulation, Coronavirus, COVID-19


Coagulopathy of Coronavirus Disease 2019
From Critical Care Medicine. Recent studies have reported a high incidence of thrombotic events in COVID-19. However, the significance of thromboembolic complications has not been widely appreciated. The purpose of this review is to provide current knowledge of this serious problem.

Anticoagulation, Coronavirus, COVID-19, Therapies


Higher Intensity Thromboprophylaxis Regimens and Pulmonary Embolism in Critically Ill Coronavirus Disease 2019 Patients
From Critical Care Medicine. In this study from Belgium, the authors assessed the role of thromboprophylaxis regimens on the occurrence of pulmonary embolism in coronavirus disease 2019 patients.

Anticoagulation, Coronavirus, COVID-19


Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation
From Critical Care Medicine. Deep venous thrombosis is very common in critically ill patients with coronavirus disease 2019, so the authors describe the prevalence of venous thromboembolism in critically ill patients receiving different regimens of prophylactic anticoagulation.

Anticoagulation, Coronavirus, COVID-19


Is there a threshold for D-dimer or fibrinogen levels to determine therapeutic doses of anticoagulation without a definitive diagnosis of venous thromboembolism?
In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were also answered. Recorded on: Friday, May 22, 2020

Anticoagulation, Coronavirus, COVID-19


Letter to Editor: In Response to "Coagulopathy of Coronavirus Disease 2019"
From Critical Care Medicine. This Letter to the Editor is in response to the article "Coagulopathy of Coronavirus 2019" by Iba et a.

Anticoagulation, Coronavirus, COVID-19


Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients - A Proof-of-Principle Trial
This study describes a simple and safe protocol of anticoagulation with low molecular weight heparin (LMWH) in combination with bedside sustained low efficiency hemodialysis (SLED) in COVID-19 patients.

Anticoagulation, Coronavirus, COVID-19


What are the options for diagnosis, workup, and treatment for a hypercoagulable state?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on July 8th, 2020.

Anticoagulation, Coronavirus, COVID-19


What are your thoughts on anticoagulation treatment?
In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues.

Anticoagulation, Coronavirus, COVID-19, Therapies


What is the recommended role of serial laboratory studies, including troponin, creatin kinase and D-dimer in the management of a hypercoagulable state?
Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

Anticoagulation, Clinical Trials, Coronavirus, COVID-19, Therapies


What is your anticoagulation protocol in COVID-19 patients?
In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were also answered. Recorded on: Friday, May 22, 2020

Anticoagulation, Coronavirus, COVID-19